Postpartum Hemorrhage
📧 Sign up to get email alerts when something new happens for Postpartum Hemorrhage.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Carbetocin at Elective Cesarean Delivery Part 3 [NA]
This entry reports a completed clinical trial update on the use of carbetocin during elective cesarean delivery for postpartum hemorrhage.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Carbetocin at Cesarean Delivery for Labor Arrest [NA]
A completed clinical trial evaluating the use of carbetocin at cesarean delivery for labor arrest to prevent postpartum hemorrhage.
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section [Phase 4]
A Phase 4 trial compared two doses of carbetocin for prevention of uterine atony during elective cesarean section. The study status is compl…
-
CLINICAL_TRIALS research · 2013-05-24Clinical Trial Update: Haemorrhagia Postpartum: an Implementation Study on the NVOG Guidelines and MOET Instructions
Update on a clinical trial evaluating the implementation of NVOG guidelines and MOET instructions for postpartum hemorrhage management.
-
FDA approval · 2013-03-29FDA Approved: METHERGINE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved a supplemental application for METHERGINE (methylergonovine maleate) submitted by Lupin Pharmaceuticals, Inc. The approval upda…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso) [NA]
This update covers the MamaMiso trial testing self-administered misoprostol to prevent postpartum hemorrhage after childbirth in community s…
-
FDA label_change · 2013-03-06FDA Approved: METHYLERGONOVINE MALEATE — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for methylergonovine maleate (American Regent, Inc.), resulting in updated labeling for this generic…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
The post-marketing surveillance trial for the Obstetrical Tamponade System was terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery [Phase 4]
Clinical trial update reporting ED90 dose determination of carbetocin for prevention of uterine atony in women undergoing elective cesarean …
-
FDA approval · 2013-02-13FDA Approved: OXYTOCIN — Original Application (West-Ward Pharmaceuticals Corp)
FDA approves the original application for an Oxytocin injectable from West-Ward Pharmaceuticals Corp, making a generic oxytocin product avai…
-
FDA approval · 2013-01-31FDA Approved: METHYLERGONOVINE MALEATE — Supplemental Application (Pharmacist Pharmaceutical, LLC)
FDA approved a supplemental application for METHYLERGONOVINE MALEATE from Pharmacist Pharmaceutical, LLC. This action approves the supplemen…
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Uterotonic Efficacy of Oxytocin 2.5 Versus 10 Units During Caesarean Section at Mulago Hospital [NA]
A completed trial comparing oxytocin dosing (2.5 units vs 10 units) during cesarean section to evaluate uterotonic efficacy and effects on u…
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section [Phase 1, Phase 2]
A clinical trial update reports results from Phase 1 and Phase 2 studies evaluating whether combining oxytocin and misoprostol reduces blood…
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Evaluation of Melatonin's Effect on Pain and Blood Loss After Cesarean Section [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluated whether melatonin can reduce pain and blood loss in patients undergoing cesarean section, and the study…
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatment [NA]
The study reports in-vitro comparisons of carbetocin versus oxytocin on myometrial contractions, with and without prior oxytocin exposure.
-
CLINICAL_TRIALS research · 2012-09-21Clinical Trial Update: In Vitro Myometrial Contractions in Laboring and Non-laboring Women [NA]
This clinical trial update describes an in vitro study of myometrial contractions in laboring and non-laboring women, with postpartum hemorr…
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP) [NA]
Feasibility trial results for the Circumferential Abdominal Pelvic Pressure Device (CAPP) in postpartum hemorrhage have been completed and r…
-
CLINICAL_TRIALS research · 2012-06-05Clinical Trial Update: Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of Labor
A clinical trial compares sublingual misoprostol to intravenous oxytocin for active management of the third stage of labor to prevent postpa…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Can Tranexamic Acid Reduce Bleeding After Post Partum Hemorrhage in Cesarean Section Delivery [Phase 4]
A Phase 4 clinical trial evaluating whether tranexamic acid reduces bleeding after postpartum hemorrhage in cesarean delivery has been compl…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Carbetocin at Elective Cesarean Delivery Part 2 [NA]
A completed trial update evaluating carbetocin for use in elective cesarean delivery to prevent postpartum hemorrhage.
-
FDA approval · 2012-03-02FDA Approved: TRANEXAMIC ACID — Original Application (Fresenius Kabi USA, LLC)
FDA approves the original application for tranexamic acid as a generic product from Fresenius Kabi USA, LLC. This marks the entry of a gener…
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Coagulation Factor Changes Associated With Postpartum Hysterectomies
This clinical trial update reports coagulation factor changes observed in women undergoing postpartum hysterectomies due to obstetric hemorr…
-
CLINICAL_TRIALS withdrawal · 2012-01-11Clinical Trial Update: Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? [Phase 4]
A Phase 4 trial evaluating intramyometrial oxytocin during elective cesarean delivery has been withdrawn. The study was associated with post…
-
CLINICAL_TRIALS withdrawal · 2012-01-09Clinical Trial Update: Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India [NA]
The clinical trial evaluating the effectiveness, safety, and feasibility of administering oxytocin via Uniject by auxiliary nurse midwives t…
-
CLINICAL_TRIALS trial_result · 2011-12-09Clinical Trial Update: Accuracy of Blood Loss Estimation After Vaginal Delivery [NA]
A completed clinical trial evaluating the accuracy of estimated blood loss after vaginal delivery has posted results. The study concerns pos…